Bisphosphonates are widely used antiresorptive agents for osteoporosis, metastatic bone disease, and other disorders of bone metabolism, but their use may lead to medication-related osteonecrosis of the jaw (MRONJ), a condition associated with impaired post-extraction healing. Statins, beyond their cholesterol-lowering effects, exhibit pleiotropic properties including anti-inflammatory, antimicrobial, and bone-regenerative activity, suggesting a potential therapeutic role in counteracting bisphosphonate-induced complications. The present study investigated the effects of local and systemic administration of atorvastatin on post-extraction wound healing, inflammatory markers, and antioxidant capacity in Wistar rats pretreated with zoledronic acid. Thirty rats were randomized into six groups, including positive and negative controls, and four experimental groups receiving different combinations of zoledronic acid and atorvastatin. Macroscopic evaluation, cone-beam computed tomography, cytokine assays, and enzymatic analyses were performed. Rats treated solely with zoledronic acid demonstrated impaired healing, necrotic bone exposure, elevated TNF-α and IL-1β, and reduced catalase, superoxide dismutase, and glutathione reductase activity. In contrast, both local and systemic atorvastatin significantly improved wound healing, reduced cytokine levels, and restored antioxidant capacity, with effects comparable or superior to the positive control group. These findings suggest that atorvastatin may mitigate zoledronic acid-induced oxidative and inflammatory imbalance, supporting its potential application for wound healing.
This study aimed to investigate the effects of articular disc perforation (DP) on condylar remodeling following disc repositioning surgery in adults with anterior disc displacement without reduction (ADDWoR). We included 77 patients with 113 joints diagnosed with ADDWoR, stratified into perforated (44 joints) and non-perforated (69 joints) groups. Three-dimensional condylar morphology was analyzed preoperatively and 6-months postoperatively using CBCT. Visual Analogue Scale (VAS) for pain relief and maximum mouth opening (MMO) were used to evaluate clinical efficacy. Statistical analyses included independent t-test and multivariate regression. No significant differences in condylar volume, height, mediolateral diameter, pain relief, or MMO was observed between groups. The increase of the anteroposterior condylar diameter was greater in the non-perforated group [0.5644 ± 1.092 mm vs. 0.1413 ± 0.8434 mm; P < 0.05]. A significant inverse correlation existed between patient age and volume change (R2 = 0.117, P < 0.001), with patients under 30 years exhibiting superior remodeling [53.02 ± 114.8 mm3 vs. -17.08 ± 148.8 mm3;P < 0.01]. DP did not adversely affect condylar remodeling in adult ADDWoR after disc repositioning surgery. Age emerged as the critical prognostic factor, with significant bone regeneration attenuated beyond 30 years, suggesting age-stratified surgical planning, potentially prioritizing disc repositioning in younger patients while exploring adjuvant biologics for elder cohorts.

